1 |
Heneghan MA, Johnson PJ, Clare M, et al (2003). Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int J Gastrointest Cancer, 34, 19-26.
|
2 |
Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
DOI
ScienceOn
|
3 |
Huang HL, Xie JS, Huang ZS, et al (2007). The Relationship of Polymorphism of Tulnor Necrosis Factor-Ot Gene Promoter-238G/A with Prhnary Hepatic Carcinoma in Patients. Progress Anatomical Sci, 13, 11-3.
|
4 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
5 |
Jeng JE, Tsai JF, Chuang LY, et al (2007). Tumor necrosis factoralpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia, 9, 987-92.
DOI
ScienceOn
|
6 |
Jeng JE, Tsai HR, Chuang LY, et al (2009). Independent and additive interactive effects among tumor necrosis factoralpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore), 88, 349-57.
DOI
ScienceOn
|
7 |
Jung KW, Ha E, Yu GI, et al (2009). TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta, 407, 16-9.
DOI
ScienceOn
|
8 |
Kummee P, Tangkijvanich P, Poovorawan Y, et al (2007). Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat, 14, 841-8.
|
9 |
Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
|
10 |
Marcos M, Gomez-Munuera M, Pastor I, et al (2009). Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol, 170, 948-56.
DOI
ScienceOn
|
11 |
Mocellin S, Nitti D (2008). TNF and cancer: the two sides of the coin. Front Biosci, 13, 2774-83.
DOI
|
12 |
Niro GA, Fontana R, Gioffreda D, et al (2005). Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int, 25, 1175-81.
DOI
ScienceOn
|
13 |
Postal M, Appenzeller S (2011). The role of Tumor Necrosis Factor-alpha (TNF-alpha) in the pathogenesis of systemic lupus erythematosus. Cytokine, 56, 537-43.
DOI
ScienceOn
|
14 |
Qidwai T, Khan F (2011). Tumour necrosis factor gene polymorphism and disease prevalence. Scand J Immunol, 74, 522-47.
DOI
ScienceOn
|
15 |
Salanti G, Amountza G, Ntzani EE, et al (2005). Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet, 13, 840-8.
DOI
ScienceOn
|
16 |
Sethi G, Shanmugam MK, Ramachandran L, et al (2012). Multifaceted link between cancer and inflammation. Biosci Rep, 32, 1-15.
DOI
ScienceOn
|
17 |
Suganuma M, Watanabe T, Yamaguchi K, et al (2012). Human gastric cancer development with TNF-alpha-inducing protein secreted from Helicobacter pylori. Cancer Lett, 322, 133-8.
DOI
ScienceOn
|
18 |
Sun SC (2012). The noncanonical NF-kappaB pathway. Immunol Rev, 246, 125-40.
DOI
ScienceOn
|
19 |
Vujanovic NL (2011). Role of TNF superfamily ligands in innate immunity. Immunol Res, 50, 159-74.
DOI
|
20 |
Walczak H (2011). TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol Rev, 244, 9-28.
DOI
ScienceOn
|
21 |
Wang J, Cao C, Luo H, et al (2011). Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis. Int J Immunogenet, 38, 311-20.
DOI
ScienceOn
|
22 |
Wang B, Huang G, Wang D, et al (2010a). Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol, 53, 508-18.
DOI
ScienceOn
|
23 |
Wang B, Wang J, Zheng Y, et al (2010b). A study of TNFalpha-238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China. Pathology, 42, 674-80.
DOI
ScienceOn
|
24 |
Wang CK, Zhang CY, Huang TR, et al (2012). Correlation between TNF- polymorphisms and family clustering of primary liver cancer in Guangxi. Chin J of Oncol Prev and Treat, 4, 149-53.
|
25 |
Wang Y, Kato N, Hoshida Y, et al (2003). Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology, 37, 65-71.
DOI
ScienceOn
|
26 |
Wiangnon S, Kamsa-ard S, Suwanrungruang K, et al (2012). Trends in incidence of hepatocellular carcinoma, 1990-2009, Khon Kaen, Thailand. Asian Pac J Cancer Prev, 13, 1065-8.
DOI
ScienceOn
|
27 |
Zhou P, Lv GQ, Wang JZ, et al (2011). The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS One, 6, e22092.
DOI
|
28 |
Chen X, Zhang L, Chang Y, et al (2011). Association of TNFalpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers, 26, 181-7.
DOI
ScienceOn
|
29 |
Aggarwal BB, Gupta SC, Kim JH (2012). Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood, 119, 651-65.
DOI
|
30 |
Bridges JF, Joy SM, Gallego G, et al (2011). Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. Asian Pac J Cancer Prev, 12, 2585-91.
|
31 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
ScienceOn
|
32 |
El-Serag HB (2011). Hepatocellular carcinoma. N Engl J Med, 365, 1118-27.
DOI
ScienceOn
|
33 |
Falvo JV, Tsytsykova AV, Goldfeld AE (2010). Transcriptional control of the TNF gene. Curr Dir Autoimmun, 11, 27-60.
DOI
ScienceOn
|
34 |
Fan W, Maoqing W, Wangyang C, et al (2011). Relationship between the polymorphism of tumor necrosis factoralpha-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet, 19, 432-7.
DOI
ScienceOn
|
35 |
Harkisoen S, Arends JE, van Erpecum KJ, et al (2012). Hepatitis B viral load and risk of HBV-related liver disease: from East to West? Ann Hepatol, 11, 164-71.
|